Merck & Co - total revenue 2006-2018

The revenue of Merck & Co. increased for the third successive year in 2018, rising from 40.1 billion U.S. dollars to approximately 42.3 billion U.S. dollars over the year. Sales of the company’s animal health products generated an estimated ten percent share of total revenue.

Revenues lifted by sales of cancer treatments

The majority of Merck’s revenue comes from its pharmaceutical segment, which includes human health and vaccine products. The company’s oncology division, which is dedicated to the study of cancer, generated the most pharmaceutical revenue in 2018. Sales of Keytruda, a drug used to fight cancer, were particularly strong during the year – revenue increased by around 3.3 billion U.S. dollars between 2017 and 2018.

The importance of investing in innovation

Higher sales of vaccine products also contributed to the increase in Merck’s revenue in 2018, primarily driven by a 36 percent rise in sales of Gardasil/Gardasil 9, which can help in the prevention of certain cancers. Developing commercially successful products, such as Keytruda and Gardasil, is essential if Merck & Co. want to compete in the industry. The company continues to recognize the importance of research and development and has annually invested around ten billion U.S. dollars in the search for innovative medicines over the last few years.

Total revenue of Merck & Co. from 2006 to 2018

Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Worldwide

Survey time period

2006 to 2018

Supplementary notes

Values for 2006-2013 were taken from previous annual financial reports.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Merck & Co."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.